分析儀器：市場佔有率分析、行業趨勢和統計數據、成長預測（2026-2031 年）

分析儀器市場預計到 2026 年將達到 590.4 億美元，到 2031 年將達到 820.8 億美元，複合年成長率為 6.81%。

這項強勁需求源自於更嚴格的污染物排放法規、3奈米以下半導體製造流程的發展，以及製藥業向即時放行檢測的轉變，所有這些都需要高靈敏度的軟體驅動平台。北美地區憑藉其大規模的生物製藥和半導體產業，預計到2025年將佔全球銷售額的39.82%。同時，亞太地區預計到2031年將以7.84%的複合年成長率成長，這主要得益於超級工廠和晶圓代工廠的擴張，對線上粒度測量系統和基於ICP-MS的品管系統的需求不斷成長。此外，全球實驗室正在加速採用基於雲端的數據管理，可攜式分析儀器的應用也正在擴展到石油和天然氣行業，因為這些行業需要即時結果。同時，替代載氣的努力也在進行中，以緩解曾經限制氣相層析法工作流程的氦氣供應限制。

全球分析儀器市場趨勢及洞察

擴大生物製藥品質保證和品管（QA/QC）中聯用技術的應用。

單株抗體和抗體藥物複合體目前佔新藥認證的30%以上，其複雜的結構使得液相層析法-高解析度質譜聯用（LC-MS）成為電荷突變和糖基化分析的正交標準。 2024年發布的監管指南明確要求在生物相似藥申報中採用LC-MS進行胜肽圖譜分析，這鞏固了對精度低於5 ppm的Orbitrap和四極飛行時間（TOF）質譜儀的需求。儀器供應商預計2025年銷售量將達到兩位數成長，其中亞洲生物相似藥研發公司採用率最高，這些公司旨在驗證分子等效性。實驗室擴大採用人工智慧模組來實現方法最佳化的自動化，從而縮短驗證週期並降低人為錯誤的風險。這一趨勢促進了高階硬體和軟體套裝的銷售以及耗材的持續收入。

全球範圍內針對 PFAS 和微塑膠的嚴格法規正在推動超微量分析技術的發展。

2024年，美國將主要全氟烷基和多氟烷基物質（PFAS）的最大污染物限值（MCL）設定為4 ppt，遠低於傳統四極質譜平台的檢測極限。因此，公共產業和私人檢測實驗室紛紛升級到電感耦合等離子體串聯質譜（ICP-MS/MS）和Orbitrap系統，這些系統配備碰撞反應池，可抑制多原子干擾，從而實現低於1 ppt的檢測極限。歐洲正在審議的微塑膠指令也推動了這一趨勢，使得利用拉曼顯微光譜和熱解-質譜聯用技術進行單顆粒級聚合物鑑定成為可能。供應商報告稱，2025年來自市政客戶的訂單激增30%以上，顯示合規性正在重新評估資本投資的優先事項。

新興市場高解析度質譜的總擁有成本較高

雖然Orbitrap和Q-TOF儀器的售價在50萬至120萬美元之間，但五年總擁有成本（包括耗材和維護合約）通常超過200萬美元。由於付款期限長達180天（是北美買家的兩倍），南亞和東南亞的許多實驗室面臨現金流緊張和儀器升級緩慢的問題。因此，小規模的機構選擇翻新的三重四極儀器或將超微量分析外包，導致需求分散和升級週期延長。供應商正在推出訂閱模式，將硬體、軟體和維護服務打包到月費中，但這種模式在跨國公司以外的普及程度仍然有限​​。

細分市場分析

到2025年，質譜分析將佔該細分市場收入的29.33%，成為分析儀器市場中佔有率最大的領域。層析法平台將位居第二，其中超高效液相層析法（UHPLC）隨著層析管粒徑縮小至2µm以下而發展迅速。分子和元素光譜分析在食品、石油化學和半導體行業的應用仍將至關重要，而分析顯微鏡和表面分析工具將為奈米材料和電池的研究提供支援。資料管理軟體和服務將成為成長最快的類別，複合年成長率（CAGR）達8.46%，反映出實驗室正向整合式資料擷取、合規性和人工智慧分析的雲端實驗室資訊管理系統（LIMS）平台轉型。這種轉變正在使軟體訂閱成為更廣泛的分析儀器市場中持續的收入來源。

色譜柱、離子源和校準標準品等耗材能夠提供穩定的現金流，並支援供應商忠誠度計畫。儀器製造商擴大提供多年耗材計劃，並結合預防性保養契約，從而簡化收入確認流程。軟體驅動成長的同時，硬體創新也轉向模組化架構，以縮短維修時間並方便現場升級。這些特性滿足了實驗室的需求，即最大限度地減少停機時間，從而最大限度地延長運轉率。

到2025年，製藥和生物製藥公司將佔市場需求的33.47%，這主要得益於它們在藥物發現篩檢、製劑開發和放行測試中對液相色譜（LC）、質譜（MS）和溶出度測試平台的依賴。同時，環境檢測實驗室正經歷最快的成長，複合年成長率（CAGR）高達8.93%，因為有關全氟烷基和多氟烷基物質（PFAS）和微塑膠的法規要求使用高解析度質譜和拉曼光譜進行超痕量檢測。因此，面向公共產業和合約環境檢測實驗室的分析儀器市場正在迅速擴張。在臨床、食品、化學和半導體領域，由於需要滿足各自法規和產能要求的專用配置，支出呈現持續多元化的趨勢。

電池與材料科學研究所正在加大對電感耦合等離子體質譜聯用儀（ICP-MS-MS）和X光繞射儀的投資，用於陰極相穩定性研究。同時，半導體晶圓廠也積極採購二次離子質譜儀（SIMS）和X光光電子能譜儀（XPS）設備，以確保3奈米以下製程的良率。學術機構和政府部門對高階顯微鏡的需求仍然強勁，但由於預算停滯，訂購頻率受到限制。總而言之，這些趨勢表明，傳統的製藥業主導地位正在向更廣泛的收入來源多元化轉變，並擴展到相關領域。

區域分析

到2025年，北美將佔全球收入的39.82%。這得歸功於美國FDA、EPA和SEMI等機構的嚴格標準，這些標準要求使用檢驗的分析方法。歐洲緊隨其後，德國、英國和法國擁有強大的製藥和化學生產基地，推動了層析法和光譜分析的支出。歐洲分析儀器市場受益於監管協調，實現了跨大西洋地區的平台標準化。

預計到2031年，亞太地區將以7.84%的複合年成長率成長，並且已經擁有成長最快的客戶群。到2025年，中國的電池超級工廠總產能將超過50吉瓦時，每個工廠都將安裝粒度分析儀、電感耦合等離子體質譜儀（ICP-MS）和X光繞射儀，以確保粉末和漿料的品質。預計到2025年，印度的藥品出口額將達到279億美元，這將推動對符合美國藥典（USP）標準並通過美國食品藥品監督管理局（FDA）檢查的液相層析-質譜聯用儀（LC-MS）和高效液相層析儀（HPLC）平台的需求。日本和韓國的半導體製造設備供應商正在擴大其二次離子質譜儀（SIMS）和掃描電子顯微鏡（SEM）的產能，以支援3奈米以下的製造程序，從而確保該地區的持續需求。

中東和非洲是戰略市場，儘管規模較小。沙烏地阿拉伯和阿拉伯聯合大公國石化產業的擴張推動了對氣相層析法和元素光譜技術的投資。巴西和阿根廷是南美洲的關鍵市場，分別專注於食品檢測和採礦業，並高度依賴電感耦合等離子體發射光譜法（ICP-OES）和紫外可見光光譜法（UV-Vis）。在澳大利亞，政府正增加對地下水監測計畫的投入，要求檢測濃度低於1 ppt的全氟烷基和多氟烷基物質（PFAS），這推動了高解析度電感耦合等離子體質譜儀（ICP-MS）在長期修復計畫中的應用。

其他好處：

• Excel格式的市場預測（ME）表
• 3個月的分析師支持

目錄

第1章：引言

• 研究假設和市場定義
• 調查範圍

第2章：調查方法

第3章執行摘要

第4章 市場狀況

• 市場概覽
• 市場促進因素
  • 生物製藥品質保證 (QA) 和品管(QC) 中聯用技術的採用率不斷提高。
  • 全球範圍內針對 PFAS 和微塑膠的嚴格法規正在推動超微量光譜技術的發展。
  • 向藥品生產中的即時放行檢測 (RTRT) 過渡
  • 隨著半導體節點小型化到 3 奈米以下，需要超高靈敏度的表面分析。
  • 可再生航空燃料計劃的擴展正在推動原料認證。
  • 為了確保電池超級工廠的質量，實驗室分析正在迅速增加。
• 市場限制因素
  • 新興市場高解析度質譜的總擁有成本較高
  • 熟練的分析化學家短缺，導致外包成本上升。
  • 氦氣供應鏈的波動影響氣相層析儀的運行
  • 受監管領域新分析方法的檢驗週期越來越長。
• 產業價值鏈分析
• 宏觀經濟因素對市場的影響
• 監理展望
• 技術展望
• 波特五力分析
  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭程度

第5章 市場規模與成長預測

• 依產品類型
  • 層析法裝置
    • 氣相層析法（GC）系統
    • 高效液相層析和超高效液相層析（HPLC、UHPLC）
    • 離子層析法（IC）系統
    • 超臨界流體層析（SFC）系統
  • 分子光譜學
    • 紫外-可見光強度
    • 傅立葉轉換紅外線光譜儀（FT-IR）
    • 近紅外線（NIR）光譜儀
    • 拉曼光譜儀
    • 螢光光強度
  • 元素光譜學
    • 原子吸收光強度（AAS）
    • 電感耦合等離子體發射光譜儀（ICP-OES）
    • 電感耦合等離子體質譜儀（ICP-MS）
    • X光螢光光譜儀
  • 質譜分析
    • 單四極桿質譜系統
    • 三重四極桿質譜系統
    • 四極桿飛行時間（Q-TOF）質譜儀
    • Orbitrap 和 FT-MS 系統
    • MALDI-TOF MS系統
  • 分析顯微鏡和成像
    • 掃描電子顯微鏡（SEM）
    • 穿透式電子顯微鏡（TEM）
    • 原子力顯微鏡（AFM）
    • 共聚焦顯微鏡和光學顯微鏡
  • 表面、熱學和顆粒表徵
    • X光衍射（XRD）設備
    • 熱分析設備（DSC、TGA 等）
    • 粒度及ZETA電位分析儀
  • 耗材和配件
  • 資料管理軟體和服務
• 按最終用戶行業分類
  • 藥品和生物製藥
    • 藥物發現和藥物開發
    • 生產品質保證和品管
  • 臨床和診斷檢查室
  • 環境檢測實驗室
  • 食品和飲料檢測
  • 化工/石油化工
  • 石油和天然氣（上游、中游、下游）
  • 材料科學與冶金
  • 半導體和電子學
  • 學術和政府附屬研究機構
  • 取證與安全
  • 用水和污水業務
• 裝置植入性別
  • 桌上型和固定式設備
  • 攜帶式和手持式設備
  • 線上和線上流程分析儀
• 按銷售管道
  • 直銷
  • 銷售代理和系統整合商
  • 電子商務市場
• 按地區
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 俄羅斯
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東和非洲
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 其他非洲地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區

第6章 競爭情勢

• 市場集中度
• 策略趨勢
• 市佔率分析
• 公司簡介
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • Danaher Corporation
  • Bruker Corporation
  • Waters Corporation
  • PerkinElmer Inc.
  • Metrohm AG
  • Mettler Toledo International Inc.
  • Malvern Panalytical Ltd.
  • Hitachi High-Tech Corporation
  • HORIBA Ltd.
  • JEOL Ltd.
  • Anton Paar GmbH
  • Bio-Rad Laboratories Inc.
  • ZEISS Group
  • Oxford Instruments plc
  • Nikon Instruments Inc.
  • Rigaku Corporation
  • LECO Corporation
  • Sartorius AG
  • Merck KGaA

第7章 市場機會與未來展望

The analytical instrumentation market size reached USD 59.04 billion in 2026 and is projected to reach USD 82.08 billion by 2031, advancing at a 6.81% CAGR.

Strong demand stems from tighter contaminant regulations, sub-3-nanometer semiconductor manufacturing, and the pharmaceutical shift to real-time release testing, all of which require highly sensitive, software-driven platforms. North America generated 39.82% of 2025 revenue, led by large biopharmaceutical and semiconductor bases, while Asia-Pacific is expected to post a 7.84% CAGR through 2031, as gigafactory and foundry build-outs favor inline particle-size and ICP-MS quality-control systems. Laboratories worldwide are also accelerating adoption of cloud-based data management, and portable analyzers are moving upstream into oil and gas fields where immediate results matter. Meanwhile, carrier-gas substitution initiatives have begun to mitigate helium supply shocks that once constrained gas chromatography workflows.

Global Analytical Instrumentation Market Trends and Insights

Rising Adoption of Hyphenated Techniques for Biologics QA/QC

Monoclonal antibodies and antibody-drug conjugates now represent more than 30% of new drug approvals, and their structural complexity has normalized liquid chromatography high-resolution mass spectrometry as the orthogonal standard for charge-variant and glycosylation profiling. Regulatory guidance issued in 2024 explicitly calls for peptide mapping via LC-MS in biosimilar dossiers, anchoring demand for Orbitrap and quadrupole-time-of-flight systems that deliver sub-5 ppm accuracy. Instrument suppliers reported double-digit unit growth in 2025, with uptake highest among Asian biosimilar developers aiming to prove molecular equivalence. Laboratories increasingly integrate AI modules that automate method optimization, shortening validation cycles and reducing human error risk. This dynamic supports premium hardware-software bundles and recurring revenue from consumables.

Stringent Global Limits on PFAS and Microplastics Boosting Ultra-Trace Spectrometry

The United States set a maximum contaminant level of 4 ppt for key PFAS species in 2024, far below the detection limits of legacy triple-quadrupole MS platforms. Utilities and commercial laboratories, therefore, upgraded to ICP-MS/MS and Orbitrap systems equipped with collision-reaction cells that suppress polyatomic interferences to achieve sub-1 ppt detection. Europe's pending microplastics directive adds momentum, as Raman microspectroscopy and pyrolysis-GC-MS enable single-particle polymer identification. Instrument vendors recorded order spikes of 30% or more from municipal customers in 2025, indicating that mandated compliance is reshaping capital-spending priorities.

High Total Cost of Ownership of High-Resolution MS in Emerging Markets

Orbitrap and Q-TOF instruments range from USD 500,000 to USD 1.2 million, but five-year ownership often exceeds USD 2 million when consumables and service contracts are included. Many laboratories in South and Southeast Asia face 180-day payment terms, double that of North American buyers, tightening cash flow and delaying replacements. Consequently, smaller facilities opt for refurbished triple-quadrupole units or outsource ultra-trace analyses, fragmenting demand and lengthening refresh cycles. Vendors respond with subscription models that bundle hardware, software, and maintenance into monthly fees, yet adoption remains modest outside multinational corporations.

Other drivers and restraints analyzed in the detailed report include:

1. Shift Toward Real-Time Release Testing in Pharma Production
2. Semiconductor Node Shrinkage Below 3 nm Requiring Ultra-Sensitive Surface Analysis
3. Shortage of Skilled Analytical Chemists Elevating Outsourcing Costs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Mass spectrometry accounted for 29.33% of segment revenue in 2025, the largest share of the analytical instrumentation market. Chromatography platforms ranked second, with ultra-high-performance liquid chromatography gaining momentum as column particle sizes shrink to sub-2 µm. Molecular and elemental spectroscopy instruments remain essential to food, petrochemical, and semiconductor workflows, while analytical microscopes and surface analysis tools support nanomaterials and battery research. Data-management software and services represent the fastest-growing category at an 8.46% CAGR, mirroring laboratory migration to cloud LIMS platforms that merge acquisition, compliance, and AI analytics. This transition positions software subscriptions as an annuity layer within the wider analytical instrumentation market.

Consumables such as columns, ion sources, and calibration standards deliver stable cash flow and underpin vendor loyalty programs. Instrument makers increasingly package multiyear consumable plans with preventive-maintenance agreements that smooth revenue recognition. With software leading growth, hardware innovation now centers on modular architectures that shorten repair times and facilitate field upgrades. These features resonate with laboratories that must minimize downtime to maximize utilization.

Pharmaceutical and biopharmaceutical companies accounted for 33.47% of demand in 2025, owing to discovery screening, formulation, and release testing that rely on LC, MS, and dissolution platforms. Environmental laboratories, however, are advancing the fastest, with an 8.93% CAGR, because PFAS and microplastics regulations mandate ultra-trace detection via high-resolution mass spectrometry and Raman spectroscopy. The analytical instrumentation market for utilities and contract environmental labs is therefore expanding rapidly. Clinical, food, chemical, and semiconductor segments continue to diversify spending, each seeking specialized configurations that match their respective regulatory and throughput requirements.

Battery and materials-science laboratories are directing fresh investment toward ICP-MS-MS and X-ray diffraction systems for cathode-phase stability studies. Semiconductor fabs, meanwhile, intensify purchases of SIMS and XPS equipment to safeguard yields below 3 nm. Academic and government institutes sustain demand for high-end microscopes, though flat budgets temper the frequency of orders. Collectively, these patterns illustrate a shift from traditional pharma dominance toward a broader distribution of revenue streams across adjacent sectors.

The Analytical Instrumentation Market Report is Segmented by Product Type (Molecular Spectroscopy, Elemental Spectroscopy, and More), End-User Industry (Food and Beverage Testing, and More), Instrument Portability (Portable and Handheld Instruments, and More), Sales Channel (Direct Sales, Distributors and System Integrators, Ecommerce Marketplaces), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America accounted for 39.82% of global revenue in 2025, underpinned by the United States' stringent FDA, EPA, and SEMI standards that require validated analytical methods. Europe followed, with Germany, the United Kingdom, and France maintaining robust pharmaceutical and chemical production bases that favor spending on chromatography and spectroscopy. The analytical instrumentation market in Europe benefited from regulatory harmonization, which enabled platform standardization across transatlantic sites.

Asia-Pacific is set to expand at a 7.84% CAGR through 2031 and already houses the fastest-growing customer segments. China's battery gigafactory footprint exceeded 50 GWh in 2025, and each plant integrates particle-size analyzers, ICP-MS units, and X-ray diffraction systems to certify the quality of powders and slurries. India's pharmaceutical exports climbed to USD 27.9 billion in fiscal 2025, boosting demand for LC-MS and HPLC platforms that meet USP monographs and pass U.S. FDA inspections. Japanese and South Korean chip-equipment suppliers are scaling SIMS and SEM capacity to support sub-3 nm fabrication, ensuring sustained regional demand.

The Middle East and Africa remain smaller but strategic, with petrochemical expansions in Saudi Arabia and the United Arab Emirates driving investments in gas chromatography and elemental spectroscopy. South America's key markets, Brazil and Argentina, focus on food testing and mining, respectively, depending heavily on ICP-OES and UV-visible spectroscopy. Australia funds groundwater-monitoring programs that mandate PFAS detection at levels below 1 ppt, thereby funding high-resolution ICP-MS instruments for long-term remediation projects.

1. Agilent Technologies Inc.
2. Thermo Fisher Scientific Inc.
3. Shimadzu Corporation
4. Danaher Corporation
5. Bruker Corporation
6. Waters Corporation
7. PerkinElmer Inc.
8. Metrohm AG
9. Mettler Toledo International Inc.
10. Malvern Panalytical Ltd.
11. Hitachi High-Tech Corporation
12. HORIBA Ltd.
13. JEOL Ltd.
14. Anton Paar GmbH
15. Bio-Rad Laboratories Inc.
16. ZEISS Group
17. Oxford Instruments plc
18. Nikon Instruments Inc.
19. Rigaku Corporation
20. LECO Corporation
21. Sartorius AG
22. Merck KGaA

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Adoption of Hyphenated Techniques for Biologics QA/QC
  • 4.2.2 Stringent Global Limits on PFAS and Micro-plastics Boosting Ultra-Trace Spectrometry
  • 4.2.3 Shift Toward Real-Time Release Testing (RTRT) in Pharma Production
  • 4.2.4 Semiconductor Node Shrinkage below 3 nm Requiring Ultra-Sensitive Surface Analysis
  • 4.2.5 Expansion of Renewable Aviation Fuel Programs Driving Feedstock Certification
  • 4.2.6 In-Lab Analytics Surge for Battery Gigafactory Quality Assurance
• 4.3 Market Restraints
  • 4.3.1 High Total Cost of Ownership of High-Resolution MS in Emerging Markets
  • 4.3.2 Shortage of Skilled Analytical Chemists Elevating Outsourcing Costs
  • 4.3.3 Helium Supply-Chain Volatility Impacting GC Operations
  • 4.3.4 Lengthy Validation Cycles for Novel Analytical Methods in Regulated Sectors
• 4.4 Industry Value Chain Analysis
• 4.5 Impact of Macroeconomic Factors on the Market
• 4.6 Regulatory Outlook
• 4.7 Technological Outlook
• 4.8 Porter's Five Forces Analysis
  • 4.8.1 Bargaining Power of Suppliers
  • 4.8.2 Bargaining Power of Buyers
  • 4.8.3 Threat of New Entrants
  • 4.8.4 Threat of Substitutes
  • 4.8.5 Degree of Competition

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Product Type
  • 5.1.1 Chromatography Instruments
    • 5.1.1.1 Gas Chromatography (GC) Systems
    • 5.1.1.2 High-Performance and Ultra-High-Performance Liquid Chromatography (HPLC, UHPLC)
    • 5.1.1.3 Ion Chromatography (IC) Systems
    • 5.1.1.4 Supercritical Fluid Chromatography (SFC) Systems
  • 5.1.2 Molecular Spectroscopy
    • 5.1.2.1 UV-Visible Spectrometers
    • 5.1.2.2 Fourier Transform Infrared (FT-IR) Spectrometers
    • 5.1.2.3 Near-Infrared (NIR) Spectrometers
    • 5.1.2.4 Raman Spectrometers
    • 5.1.2.5 Fluorescence Spectrometers
  • 5.1.3 Elemental Spectroscopy
    • 5.1.3.1 Atomic Absorption Spectrometers (AAS)
    • 5.1.3.2 ICP-Optical Emission Spectrometers (ICP-OES)
    • 5.1.3.3 ICP-Mass Spectrometers (ICP-MS)
    • 5.1.3.4 X-Ray Fluorescence (XRF) Spectrometers
  • 5.1.4 Mass Spectrometry
    • 5.1.4.1 Single Quadrupole MS Systems
    • 5.1.4.2 Triple Quadrupole MS Systems
    • 5.1.4.3 Quadrupole-Time-of-Flight (Q-TOF) MS Systems
    • 5.1.4.4 Orbitrap and FT-MS Systems
    • 5.1.4.5 MALDI-TOF MS Systems
  • 5.1.5 Analytical Microscopes and Imaging
    • 5.1.5.1 Scanning Electron Microscopes (SEM)
    • 5.1.5.2 Transmission Electron Microscopes (TEM)
    • 5.1.5.3 Atomic Force Microscopes (AFM)
    • 5.1.5.4 Confocal and Optical Microscopes
  • 5.1.6 Surface, Thermal and Particle Characterisation
    • 5.1.6.1 X-Ray Diffraction (XRD) Systems
    • 5.1.6.2 Thermal Analysis Instruments (DSC, TGA, etc.)
    • 5.1.6.3 Particle Size and Zeta Potential Analysers
  • 5.1.7 Consumables and Accessories
  • 5.1.8 Data Management Software and Services
• 5.2 By End-User Industry
  • 5.2.1 Pharmaceuticals and Biopharmaceuticals
    • 5.2.1.1 Drug Discovery and Development
    • 5.2.1.2 Manufacturing QA/QC
  • 5.2.2 Clinical and Diagnostics Laboratories
  • 5.2.3 Environmental Testing Laboratories
  • 5.2.4 Food and Beverage Testing
  • 5.2.5 Chemical and Petrochemical
  • 5.2.6 Oil and Gas (Upstream, Midstream, Downstream)
  • 5.2.7 Materials Science and Metallurgy
  • 5.2.8 Semiconductor and Electronics
  • 5.2.9 Academic and Government Research Institutes
  • 5.2.10 Forensic and Security
  • 5.2.11 Water and Wastewater Utilities
• 5.3 By Instrument Portability
  • 5.3.1 Benchtop and Floor-Standing Instruments
  • 5.3.2 Portable and Handheld Instruments
  • 5.3.3 In-Line and On-Line Process Analysers
• 5.4 By Sales Channel
  • 5.4.1 Direct Sales
  • 5.4.2 Distributors and System Integrators
  • 5.4.3 eCommerce Marketplaces
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Russia
    • 5.5.2.5 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 Middle East
      • 5.5.4.1.1 Saudi Arabia
      • 5.5.4.1.2 United Arab Emirates
      • 5.5.4.1.3 Rest of Middle East
    • 5.5.4.2 Africa
      • 5.5.4.2.1 South Africa
      • 5.5.4.2.2 Egypt
      • 5.5.4.2.3 Rest of Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share for Key Companies, Products and Services, and Recent Developments)
  • 6.4.1 Agilent Technologies Inc.
  • 6.4.2 Thermo Fisher Scientific Inc.
  • 6.4.3 Shimadzu Corporation
  • 6.4.4 Danaher Corporation
  • 6.4.5 Bruker Corporation
  • 6.4.6 Waters Corporation
  • 6.4.7 PerkinElmer Inc.
  • 6.4.8 Metrohm AG
  • 6.4.9 Mettler Toledo International Inc.
  • 6.4.10 Malvern Panalytical Ltd.
  • 6.4.11 Hitachi High-Tech Corporation
  • 6.4.12 HORIBA Ltd.
  • 6.4.13 JEOL Ltd.
  • 6.4.14 Anton Paar GmbH
  • 6.4.15 Bio-Rad Laboratories Inc.
  • 6.4.16 ZEISS Group
  • 6.4.17 Oxford Instruments plc
  • 6.4.18 Nikon Instruments Inc.
  • 6.4.19 Rigaku Corporation
  • 6.4.20 LECO Corporation
  • 6.4.21 Sartorius AG
  • 6.4.22 Merck KGaA

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment